Literature DB >> 21933614

Serum major-histocompatibility-complex class I-related chain A antibody detection for the evaluation of graft dysfunction in renal allograft recipients.

Ming Zhang1, Fu-ming Lu, Lian-xi Qu, Jun He, Xiao-niao Yuan, Yong Gu.   

Abstract

BACKGROUND: In addition to the well-known antibodies against human leukocyte antigens (HLA)-induced kidney-graft rejection, polymorphic major-histocompatibility-complex (MHC) class I-related chain A (MICA) antigens can elicit antibodies and have been suggested to play a role in the antibody-mediated allograft rejection (AMR). We carried out a prospective study of MICA antibodies in post-renal transplant patients to determine the association between MICA antibodies, C4d staining, histological features, and graft outcome.
METHODS: We tested 52 patients who had biopsy results due to graft dysfunction. The MICA antibodies in concurrent sera were determined by Luminex. All patients were followed up for one year after renal biopsy. The influence of antibody production on the function of graft was analyzed.
RESULTS: Antibodies against MICA were positive in 15 out of the 52 patients (28.9%). The presence of MICA antibodies was associated with renal-allograft deterioration. During one-year follow-up, the estimated glomerular filtration rate (eGFR) decreased (24.0 ± 3.4)% among recipients with anti-MICA antibodies. However, among recipients without anti-MICA antibodies, the eGFR has declined only (8.4 ± 3.0)% (P = 0.017). The association between C4d staining, histological features and MICA antibody production was found no significant difference.
CONCLUSION: Besides anti-HLA antibodies, the presence of post-transplant MICA antibody is associated with poor graft outcome and increases the risk of graft failure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21933614

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  4 in total

1.  Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients.

Authors:  Chisa Yamada; Daniel S Ramon; Marilia Cascalho; Randall S Sung; Alan B Leichtman; Milagros Samaniego; Robertson D Davenport
Journal:  Transfusion       Date:  2014-11-11       Impact factor: 3.157

2.  Antibody-mediated rejection: pathogenesis, prevention, treatment, and outcomes.

Authors:  Olivia R Blume; Sarah E Yost; Bruce Kaplan
Journal:  J Transplant       Date:  2012-03-24

Review 3.  MICA and NKG2D: Is There an Impact on Kidney Transplant Outcome?

Authors:  Matilde Risti; Maria da Graça Bicalho
Journal:  Front Immunol       Date:  2017-02-27       Impact factor: 7.561

4.  Role of Anti-MICA Antibodies in Graft Survival of Renal Transplant Recipients of India.

Authors:  Mohit Chowdhry; R N Makroo; Mandhata Singh; Manoj Kumar; Yogita Thakur; Vandana Sharma
Journal:  J Immunol Res       Date:  2018-04-05       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.